ISRG
66
-2
AN
57
5
ILMN
42
-4
GOOGL
58
2
EA
52
3
KLAC
63
-5
VRSN
60
3
NAVI
40
4
CVX
40
8
DNB
66
2
AON
56
4
HSIC
57
6
MAR
65
2
ETN
78
-2
HOG
56
4
SIG
64
3
CHRW
53
2
DVA
75
2
WMB
62
2
BMY
63
3
ISRG
66
-2
AN
57
5
ILMN
42
-4
GOOGL
58
2
EA
52
3
KLAC
63
-5
VRSN
60
3
NAVI
40
4
CVX
40
8
DNB
66
2
AON
56
4
HSIC
57
6
MAR
65
2
ETN
78
-2
HOG
56
4
SIG
64
3
CHRW
53
2
DVA
75
2
WMB
62
2
BMY
63
3
Financhill
Back

Vinci Partners Investments Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
47

VINP
Vinci Partners Investments

Last Price:
9.89
Seasonality Move:
-11.91%
Sell
36

SRPT
Sarepta Therapeutics

Last Price:
124.65
Seasonality Move:
-1.39%
Sell
47
Vinci Partners Investments (VINP) is a Sell

Is Vinci Partners Investments a Buy, Sell or Hold?

  • The current Vinci Partners Investments [VINP] share price is $9.89. The Score for VINP is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • VINP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VINP Stock Price Chart

What is Vinci Partners Investments's stock price today?

  • The Vinci Partners Investments share price today is $9.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VINP is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $124.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

VINP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 44.36 Sell
Chaikin Money Flow: 27532 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.71 - 10.59) Sell
Bollinger Bands (100): (10.23 - 11.19) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.18 Sell
Relative Strength Index (14 RSI): 35.54 Sell
Chaikin Money Flow: -49995 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.27 - 135.95) Sell
Bollinger Bands (100): (123.89 - 147.49) Sell

VINP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.78 Buy
20-day SMA: 9.95 Sell
50-day SMA: 10.56 Sell
200-day SMA: 10.79 Sell
8-day EMA: 9.77 Buy
20-day EMA: 10.01 Sell
50-day EMA: 10.38 Sell
200-day EMA: 10.59 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.45 Sell
20-day SMA: 127.75 Sell
50-day SMA: 135.2 Sell
200-day SMA: 127.53 Sell
8-day EMA: 125.39 Sell
20-day EMA: 128.04 Sell
50-day EMA: 132.59 Sell
200-day EMA: 128.64 Sell

Vinci Partners Investments Earnings Growth & VINP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.10 per share, a decrease this year of $0.19 per share, and an increase next year of $0.20 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.

Vinci Partners Investments Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):